m+Medelevator.RU
← Поиск публикаций
AIDS care · 2025

Changes in caregiver psychosocial factors known to affect pediatric HIV disclosure: the Sankofa clinical trial experience in Ghana (2013-2023).

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Afrane Adwoa K A, Bobbala Arthi, Martyn-Dickens Charles, Renner Lorna, Antwi Sampson, Kusah Jonas Tettey, Amissah Kofi, Quaye Debora, Bosomtwe Dennis, Gan Geliang, Parziale Stephen, Reynolds Nancy R, Paintsil Elijah, Shabanova Veronika, Sankofa Study Team

Аннотация

This comparative study analyzed changes in caregiver-related factors known to influence pediatric HIV disclosure using baseline data from two clinical trials in Ghana - Sankofa 1 (recruitment 2013-2016) and Sankofa 2 (recruitment 2021-2023). Changes in caregiver characteristics and psychosocial domains were measured using validated instruments: social support (Social Provisions Scale), HIV knowledge (Brief HIV Knowledge Questionnaire), illness perception (Brief Illness Perception Questionnaire) and HIV stigma (HIV Stigma Scale). Caregivers of children aged 7-18 years who had not disclosed the child's HIV status completed the same structured questionnaires at baseline. Changes from Sankofa 1 to Sankofa 2 baseline periods in psychosocial domains were modeled using multivariable linear regressions. Compared to Sankofa 1, caregivers in Sankofa 2 were more likely to be female (85.6% vs. 81.6%), single (19.7% vs. 13.9%), without formal education (20.5% vs. 16.3%), HIV positive (66.0% vs. 60.2%) and earn higher incomes (47.1% vs. 27.6% > 300 GHS/month). From Sankofa 1 to Sankofa 2, social support changed only modestly (mean difference: 0.89, 95% Confidence Interval [CI]: - 0.15, 0.92), illness perception worsened (4.48, 95% CI: 3.16, 5.80), stigma increased (2.25, 95% CI: 1.54, 2.95) and HIV knowledge declined (-1.02, 95% CI: -1.29, -0.74). HIV status and younger age were consistently linked to higher stigma.Trial registration: ClinicalTrials.gov identifier: NCT01701635.Trial registration: ClinicalTrials.gov identifier: NCT04791865.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты